Update following Attana’s participation at Biotech Showcase

Earlier this January, Attana participated at the conference Biotech Showcase to present the company and participate in meetings with potential customers, strategic partners and investors. The conference was held digitally and involved both Swedish and international actors.

Attana experienced a strong interest in the company and the presentation that was held. In addition, the company also participated in several digital meetings with other interesting participants. The conference has led to dialogues being initiated with potential customers for contract research and instrument sales, as well as diagnostics.

Watch Attana’s presentation from the event here: https://www.attana.com/investors/

For more information, please contact:

Teodor Aastrup, CEO
teodor.aastrup@attana.com
+46 (0)8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.

About Attana

Attana was founded in 2002 with the vision of in vitro characterization of molecular interactions mimicking in vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays and the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool. Attana products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about our latest services and products, please visit www.attana.com or contact sales@attana.com

Tags: